On Jan. 28, Stryker Corp. announced plans to sell its U.S. spinal implant business to investment firm Viscogliosi Brothers. Though Stryker has a major share in the U.S. spine and orthopedic market, ...

Stryker (NYSE:SYK) reported operating results for the fourth quarter and full year of 2024: Fourth Quarter Results Reported net sales increased 10.7% ...

Lake Street analyst Brooks O’Neil notes that Stryker (SYK) announced a definitive agreement for the sale of its U.S. spinal implants business ...

By adopting this groundbreaking technology, Long Beach Medical Center reaffirms its commitment to providing the highest level ...

Stryker Corporation (NYSE:SYK), a leading player in the medical technology industry with a substantial market capitalization of $149 billion, has been making waves with its strong financial ...

Here are eight things for ASCs to know about the sale: 1. Stryker's U.S. spine segment will be sold to investment firm Viscogliosi Brothers. 2. That group will create VB Spine, which will be a ...

Stryker is selling its U.S. spinal implant business to investment firm Viscogliosi Brothers, a move that is expected to help the company ...

“We believe that the spinal implants business, with its comprehensive portfolio and strong sales channel, will thrive as an ...

Stryker is selling off its spine implant business—starting with a plan to spin off its U.S. operations before moving on to ...

Stryker reported goodwill and other impairments of $818 million related to the spine business in the fourth quarter.

Stryker forecast adjusted per-share profit for 2025 to be in the range of $13.45 to $13.70, the midpoint of which was above ...

Highlights,Strategic partnership maintains exclusive access to Mako Spine and Copilot technologies,Expected faster growth ...